Ontology highlight
ABSTRACT:
SUBMITTER: Sklavenitis-Pistofidis R
PROVIDER: S-EPMC10019228 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
Cancer cell 20221101 11
Patients with smoldering multiple myeloma (SMM) are observed until progression, but early treatment may improve outcomes. We conducted a phase II trial of elotuzumab, lenalidomide, and dexamethasone (EloLenDex) in patients with high-risk SMM and performed single-cell RNA and T cell receptor (TCR) sequencing on 149 bone marrow (BM) and peripheral blood (PB) samples from patients and healthy donors (HDs). We find that early treatment with EloLenDex is safe and effective and provide a comprehensive ...[more]